Of particular interest, brain metastasis in EGFR mutation positive NSCLC is a common site of involvement at diagnosis and treatment failure—occurring in up to 23% of newly diagnosed patients [15]. The gene discussed is EGFR; the disease is non-small cell lung carcinoma.